코스모신소재Cosmo Advanced Materials & TechnologyCosmo Advanced Materials & Technology — 상위 거래처 세 곳이 매출의 73% — 양극재 라인 가동률 13%, 고객이 물량을 정한다The top three customers take 73% of revenue — cathode line utilisation 13%; customers set the volume上位取引先3社が売上の73% — 正極材ラインの稼働率13%、数量を決めるのは顧客
DART 정기보고서(사업·반기·분기) 원문을 2014년부터 다시 받아 최종 고객이 누구인지(회사가 적은 고객사 이름·매출 10% 이상 고객·수요처), 원료를 어디서 얼마에 사는지, 그리고 그 제품과 원료가 관세청 수출입 통계(금액·물량·단가·상대국)에서 어떻게 움직이는지를 한 장에 놓았다. 마지막에 관세청 단가로 이익률 함수를 세우고 유가 → 나프타 → 제품·원료 단가로 다음 분기들을 잇는 우리 Fcst 를 붙였다. 방향을 단정하지 않고, 회사가 사고파는 값이 이익률에 어떻게 옮겨 가는지만 관측한다.The full text of DART periodic reports (annual, half-year, quarterly) is downloaded again from 2014 to put on one page who the end customers are (customer names the company gives, customers above 10% of revenue, demand sectors), where and at what price raw materials are bought, and how those products and raw materials move in Korea Customs trade statistics (value, volume, unit price, partner country). At the end, a margin function built on customs unit prices is joined by our Fcst, which links the coming quarters through oil → naphtha → product and raw-material unit prices. No direction is asserted; the page only observes how the prices at which the company buys and sells pass through to its margin.DART定期報告書(事業・半期・四半期)の原文を2014年から取り直し、最終顧客が誰か(会社が記した顧客名・売上10%以上の顧客・需要先)、原料をどこからいくらで買っているか、そしてその製品と原料が関税庁の輸出入統計(金額・数量・単価・相手国)でどう動いているかを一枚にまとめた。最後に関税庁の単価で利益率関数を立て、原油 → ナフサ → 製品・原料単価で次の四半期をつなぐ当サイトFcstを付けた。方向は断定せず、会社が売買する価格が利益率にどう波及するかだけを観測する。
먼저 보는 세 줄Three lines firstまず見る三行
Created 2026-11-13- 상위 거래처 세 곳이 매출의 73% — 양극재 라인 가동률 13%, 고객이 물량을 정한다.The top three customers take 73% of revenue — cathode line utilisation 13%; customers set the volume.上位取引先3社が売上の73% — 正極材ラインの稼働率13%、数量を決めるのは顧客。
- 영업이익률 TTM 1.3% (~2026Q2) · 매출 FY2025 4,563억 · P/B 2.07배 · 우리 Fcst 다음 4분기 P/E 77.9배.Operating margin TTM 1.3% (to 2026Q2) · revenue FY2025 KRW 456.3bn · P/B 2.07x · our Fcst next-four-quarter P/E 77.9x.営業利益率TTM 1.3%(〜2026Q2) · 売上高 FY2025 4,563億ウォン · PBR 2.07倍 · 当サイトFcstの次の4四半期PER 77.9倍。
- 우리 Fcst: 2026Q3 영업이익률 3.9% (관세청 실측 3/3달) — 전진 검증 평균 오차 1.05%p vs 직전 분기 유지 1.25%p.Our Fcst: 2026Q3 operating margin 3.9% (customs data for 3 of 3 months) — mean forward-test error 1.05pp vs 1.25pp for the previous quarter carried forward.当サイトFcst: 2026Q3の営業利益率3.9%(関税庁の実測3/3か月)— フォワードテストの平均誤差1.05%pt(前四半期据え置きは1.25%pt)。
① 최종 고객 구조 — 원료 → 제품 → 직접 고객 → 최종 수요End-customer structure — raw materials → products → direct customers → final demand最終顧客の構造 — 原料 → 製品 → 直接の顧客 → 最終需要
회사가 적은 이름·문구 그대로names and wording as the company wrote them会社が記した名前・文言のまま · Data as of 2025-12 · Created 2026-11-13매출의 72%가 양극재, 25%가 기능성필름(MLCC 이형필름)이다. 사업보고서가 이름을 밝힌 주요 매출처: 삼성전기·삼성SDI·엘지화학. 주석의 10% 이상 거래처 4곳이 매출의 85%(2025) — 이름은 가린 기호로만 나온다.72% of revenue is Cathode Materials and 25% is Functional Film. Main customers the annual report names: 삼성전기·삼성SDI·엘지화학. The notes’ 4 customers above 10% take 85% of revenue (2025) — names appear only as masked labels.売上の72%が正極材、25%が機能性フィルムだ。事業報告書が名前を明かした主要な売上先: 삼성전기·삼성SDI·엘지화학。注記の10%以上の取引先4社が売上の85%(2025)— 名前は伏せた記号でしか出ない。
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
② 매출 10% 이상 고객 — 얼마나 몰려 있나Customers above 10% of revenue — how concentrated?売上10%以上の顧客 — どれだけ集中しているか
% of revenue · Data as of 2025-12 · Created 2026-11-13주석의 '주요 고객' 공시(단일 외부고객 매출이 연결·별도 매출의 10% 이상이면 금액을 적는다). '없음'은 회사가 그렇게 적은 해다. 10% 이상 고객이 처음 공시된 해는 2014년이다. 한 고객의 비중이 가장 컸던 해는 2018년(70%).From the notes’ 'major customers' disclosure (the amount is given when revenue from a single external customer is 10% or more of consolidated or separate revenue). 'None' marks a year in which the company wrote exactly that. Customers above 10% were first disclosed in 2014. The largest single-customer share came in 2018 (70%).注記の「主要顧客」開示(単一の外部顧客への売上が連結・個別売上の10%以上なら金額を記す)。「なし」は会社がそう記した年だ。10%以上の顧客が初めて開示されたのは2014年だ。1社の比率が最も大きかったのは2018年(70%)。
| 연도Year年 | 회사 표기Company’s label会社の表記 | 매출(억원)Revenue (KRW 100mn)売上高(億ウォン) | 매출 대비Share of revenue売上比 | 회사 설명Company’s note会社の説明 |
|---|---|---|---|---|
| 2025 | 주요거래선 (A)주요거래선 (A)주요거래선 (A) | 1,670 | 36.6% | |
| 주요거래선 (B)주요거래선 (B)주요거래선 (B) | 991 | 21.7% | ||
| 주요거래선 (C)주요거래선 (C)주요거래선 (C) | 676 | 14.8% | ||
| 주요거래선 (D)주요거래선 (D)주요거래선 (D) | 533 | 11.7% | ||
| 2024 | 주요거래선 (A)주요거래선 (A)주요거래선 (A) | 2,079 | 36.5% | |
| 주요거래선 (B)주요거래선 (B)주요거래선 (B) | 975 | 17.1% | ||
| 주요거래선 (C)주요거래선 (C)주요거래선 (C) | 851 | 14.9% | ||
| 주요거래선 (D)주요거래선 (D)주요거래선 (D) | 837 | 14.7% | ||
| 2023 | 주요거래처(A)주요거래처(A)주요거래처(A) | 2,868 | 45.5% | |
| 주요거래처(B)주요거래처(B)주요거래처(B) | 1,748 | 27.8% | ||
| 주요거래처(C)주요거래처(C)주요거래처(C) | 891 | 14.2% | ||
| 2022 | 주요거래처(A)주요거래처(A)주요거래처(A) | 2,745 | 56.5% | |
| 주요거래처(B)주요거래처(B)주요거래처(B) | 861 | 17.7% | ||
| 2021 | 주요거래처(A)주요거래처(A)주요거래처(A) | 1,055 | 34.5% | |
| 주요거래처(B)주요거래처(B)주요거래처(B) | 962 | 31.4% | ||
| 주요거래처(C)주요거래처(C)주요거래처(C) | 582 | 19.0% | ||
| 2020 | 주요거래처(A)주요거래처(A)주요거래처(A) | 857 | 42.0% | |
| 주요거래처(B)주요거래처(B)주요거래처(B) | 446 | 21.9% | ||
| 주요거래처(C)주요거래처(C)주요거래처(C) | 385 | 18.9% | ||
| 주요거래처(D)주요거래처(D)주요거래처(D) | 59 | 2.9% | ||
| 주요거래처(E)주요거래처(E)주요거래처(E) | 11 | 0.6% | ||
| 2019 | 주요거래처(A)주요거래처(A)주요거래처(A) | 1,113 | 45.6% | |
| 주요거래처(B)주요거래처(B)주요거래처(B) | 705 | 28.9% | ||
| 주요거래처(C)주요거래처(C)주요거래처(C) | 228 | 9.3% | ||
| 2018 | 주요거래처(A)주요거래처(A)주요거래처(A) | 3,733 | 69.9% | |
| 주요거래처(B)주요거래처(B)주요거래처(B) | 464 | 8.7% | ||
| 주요거래처(C)주요거래처(C)주요거래처(C) | 829 | 15.5% | ||
| 2017 | 공시를 찾지 못함Disclosure not found開示が見つからない | |||
| 2016 | 공시를 찾지 못함Disclosure not found開示が見つからない | |||
| 2015 | 공시를 찾지 못함Disclosure not found開示が見つからない | |||
| 2014 | 주요거래처(A)주요거래처(A)주요거래처(A) | 535 | —% | |
| 주요거래처(B)주요거래처(B)주요거래처(B) | 377 | —% | ||
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
③ 수출·내수 — 제품별로 얼마나 밖에 파나Exports vs domestic — how much each product sells abroad輸出・内需 — 製品ごとにどれだけ海外で売るか
% export · Data as of 2025-12 · Created 2026-11-13사업의 내용 '매출실적' 표의 수출·내수(당기). 로컬 L/C 수출(국내 수출업체를 거친 것)을 수출로 넣는 회사가 있다 — 회사 표기 그대로다.Exports and domestic sales from the 'sales performance' table in the business section (current period). Some companies count local L/C exports (sales routed through domestic exporters) as exports — shown as the company reports it.事業の内容「売上実績」表の輸出・内需(当期)。ローカルL/C輸出(国内の輸出業者を経たもの)を輸出に含める会社がある — 会社の表記のままだ。
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
④ 지역별 매출 — 고객이 어디 있나Revenue by region — where the customers are地域別売上 — 顧客はどこにいるか
% of revenue · Data as of 2025-12 · Created 2026-11-13주석의 지역별 매출(당기). 지역 묶음은 회사가 해마다 다르게 적는다(예: 아시아 ↔ 아시아/오세아니아) — 같은 이름만 이었다.Revenue by region from the notes (current period). The company groups regions differently from year to year (e.g. Asia ↔ Asia/Oceania) — only identical names are linked.注記の地域別売上(当期)。地域のまとめ方は会社が年ごとに変える(例: アジア ↔ アジア/オセアニア)— 同じ名前だけをつないだ。
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑤ 원재료 — 회사 매입가 vs 관세청 수입 단가Raw materials — company purchase price vs customs import unit price原材料 — 会社の仕入価格 vs 関税庁の輸入単価
ratio (company ÷ customs) · USD/t · Data as of 2026-09 · Created 2026-11-13사업보고서 '주요 원재료 가격변동추이'의 매입 단가를 관세청 수입 단가(전 국가 합, 금액 ÷ 중량)와 같은 해·같은 단위(달러/톤)로 놓았다. 1에 가까우면 회사가 시장 수입가에 산다는 뜻이다. 최근 해: 코발트 산화물·수산화물 1.15배 · 수산화리튬 1.30배 · NCM 전구체(수산화물) 1.01배 · PET 필름 0.90배.The purchase prices in the annual report’s 'price trends of major raw materials' are set against customs import unit prices (all countries, value ÷ weight) for the same year and in the same unit (USD per tonne). A ratio near 1 means the company buys at the market import price. Latest year: Cobalt oxides/hydroxides 1.15x · Lithium hydroxide 1.30x · NCM precursor 1.01x · PET film 0.90x.事業報告書「主要原材料の価格変動推移」の仕入単価を、関税庁の輸入単価(全ての国の合計、金額 ÷ 重量)と同じ年・同じ単位(ドル/トン)で並べた。1に近ければ会社が市場の輸入価格で買っているという意味だ。直近の年: コバルト酸化物・水酸化物 1.15倍 · 水酸化リチウム 1.30倍 · NCM前駆体 1.01倍 · PETフィルム 0.90倍。
| 회사 원재료 표Company raw-material table会社の原材料表 | 관세청 품목Customs item関税庁の品目 | 최근 해Latest year直近の年 | 회사 $/tCompany $/t会社 $/t | 관세청 수입 $/tCustoms import $/t関税庁の輸入 $/t | 배율Ratio倍率 | 비고Note備考 |
|---|---|---|---|---|---|---|
| 코발트 CobaltCobaltコバルト | 코발트 산화물·수산화물Cobalt oxides/hydroxidesコバルト酸化物・水酸化物 | 2025 | 25,511 | 22,161 | 1.15 | |
| 리튬Lithiumリチウム | 수산화리튬Lithium hydroxide水酸化リチウム | 2025 | 17,878 | 13,800 | 1.30 | 회사 표 '리튬' 은 수산화·탄산 구분 없음 — 관세청 수산화리튬과 나란히(탄산리튬도 따로 봄)The company table’s 'lithium' does not distinguish hydroxide from carbonate — set beside customs lithium hydroxide (lithium carbonate is also viewed separately)会社の表の「リチウム」は水酸化物と炭酸塩の区別がない — 関税庁の水酸化リチウムと並べた(炭酸リチウムも別に見る) |
| 전구체 NCM-PPrecursor NCM-P前駆体 NCM-P | NCM 전구체(수산화물)NCM precursorNCM前駆体 | 2025 | 12,749 | 12,602 | 1.01 | |
| 베이스필름 Ba efilmBase filmベースフィルム | PET 필름PET filmPETフィルム | 2025 | 2,529 | 2,802 | 0.90 | 국내 조달(회사 표 '국내') — 관세청 PET 필름 수입 단가는 시장 참고Sourced domestically ('domestic' in the company table) — the customs PET film import unit price is a market reference国内調達(会社の表の「国内」)— 関税庁のPETフィルム輸入単価は市場の参考 |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑥ 제품 — 회사 판가·생산량 vs 관세청 수출Products — company selling price and output vs customs exports製品 — 会社の販売価格・生産量 vs 関税庁の輸出
ratio · t · Data as of 2026-09 · Created 2026-11-13생산량은 같은 제품의 한국 전체 수출 물량과 견준다 — 양극재 NCM 2025년 회사 818톤 vs 한국 수출 153,084톤. Output is compared with Korea’s total export volume of the same product — Cathode NCM 2025: company 818 t vs Korea exports 153,084 t.生産量は同じ製品の韓国全体の輸出数量と比べる — 正極材 NCM 2025年 会社818トン vs 韓国の輸出153,084トン。
| 회사 표Company table会社の表 | 관세청 품목Customs item関税庁の品目 | 최근 해Latest year直近の年 | 회사Company会社 | 관세청Customs関税庁 | 배율Ratio倍率 | 비고Note備考 |
|---|---|---|---|---|---|---|
| 양극활물질Cathode active material正極活物質 | 양극재 NCMCathode NCM正極材 NCM | 2025 | 818 t | 153,084 t (수출) t (exports) t(輸出) | 0.01 | 회사 생산량(톤) vs 한국 NCM 양극재 수출 물량Company output (tonnes) vs Korea’s NCM cathode export volume会社の生産量(トン)vs 韓国のNCM正極材の輸出数量 |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑦ 제품 수출입 — 한국 전체 물량·단가(월별)Product trade — Korea-wide volume and unit price (monthly)製品の輸出入 — 韓国全体の数量・単価(月次)
kt · USD/t · Data as of 2026-09 · Created 2026-11-13회사가 만드는 제품을 관세청 품목으로 짝지어 한국 전체 수출 물량과 수출 단가를 매달 이었다. 최근 12개월 합과 전년 같은 기간 대비, 주요 목적국은 표에.The company’s products are matched to customs items to link Korea’s total export volume and export unit price month by month. The latest 12-month total, the change on the same period a year earlier and the main destinations are in the table.会社が作る製品を関税庁の品目に対応させ、韓国全体の輸出数量と輸出単価を毎月つないだ。直近12か月の合計と前年同期比、主な仕向国は表に。
| 제품(관세청 품목)Product (customs item)製品(関税庁の品目) | 수출 백만$Exports $mn輸出 百万ドル | 수출 ktExports kt輸出 kt | 물량 YoYVolume YoY数量 前年比 | 수출 $/tExport $/t輸出 $/t | 단가 YoYPrice YoY単価 前年比 | 수입 ktImports kt輸入 kt | 주요 목적국(금액 비중)Main destinations (share of value)主な仕向国(金額比率) |
|---|---|---|---|---|---|---|---|
| 양극재 NCMCathode NCM正極材 NCM | 3,718 | 148.5 | -5.7% | 25,042 | +7.3% | 83.4 | China 54% · United States 21% · Hungary 12% · Indonesia 5% · Poland 4% |
| 양극재 NCACathode NCA正極材 NCA | 1,613 | 61.2 | +31.0% | 26,333 | -2.7% | 0.1 | China 32% · Hungary 32% · Malaysia 20% · United States 14% · Japan 2% |
| 코발트산리튬(LCO)LCOLCO | 23 | 0.5 | -75.5% | 44,736 | +33.5% | 1.8 | Japan 75% · China 24% · United States 0% · Germany 0% · Luxembourg 0% |
| 양극재 NCMACathode NCMA正極材 NCMA | 0 | 0.0 | -97.3% | 165,186 | +640.4% | 0.0 | United States 100% · China 0% |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑧ 원료 수입 — 한국 전체 물량·단가(월별)Raw-material imports — Korea-wide volume and unit price (monthly)原料の輸入 — 韓国全体の数量・単価(月次)
kt · USD/t · Data as of 2026-09 · Created 2026-11-13원재료 표의 품목을 관세청 품목으로 짝지어 한국 전체 수입 물량·단가·원산국을 이었다.Items in the raw-material table are matched to customs items to link Korea’s total import volume, unit price and countries of origin.原材料表の品目を関税庁の品目に対応させ、韓国全体の輸入数量・単価・原産国をつないだ。
| 원료(관세청 품목)Raw material (customs item)原料(関税庁の品目) | 수입 백만$Imports $mn輸入 百万ドル | 수입 ktImports kt輸入 kt | 물량 YoYVolume YoY数量 前年比 | 수입 $/tImport $/t輸入 $/t | 단가 YoYPrice YoY単価 前年比 | 주요 원산국(금액 비중 · $/t)Main origins (share of value · $/t)主な原産国(金額比率 · $/t) |
|---|---|---|---|---|---|---|
| NCM 전구체(수산화물)NCM precursorNCM前駆体 | 1,281 | 90.5 | -4.2% | 14,160 | +14.9% | China 75% ($13,803) · Indonesia 17% ($15,141) · Morocco 5% ($14,823) · Finland 3% ($17,492) · Japan 0% ($16,242) |
| 수산화리튬Lithium hydroxide水酸化リチウム | 1,201 | 68.1 | +13.6% | 17,636 | +28.4% | China 47% ($18,464) · Indonesia 27% ($20,384) · Chile 19% ($14,027) · Argentina 2% ($17,514) · Australia 2% ($12,949) |
| PET 필름PET filmPETフィルム | 368 | 139.0 | +3.3% | 2,645 | -10.1% | Japan 40% ($8,157) · China 27% ($1,814) · Thailand 20% ($1,625) · Indonesia 7% ($3,069) · United States 1% ($10,675) |
| 탄산리튬Lithium carbonate炭酸リチウム | 291 | 19.6 | -20.9% | 14,871 | +10.8% | Chile 85% ($14,674) · China 8% ($16,570) · United States 5% ($14,011) · Switzerland 1% ($19,250) · India 0% ($87,913) |
| 코발트 산화물·수산화물Cobalt oxides/hydroxidesコバルト酸化物・水酸化物 | 62 | 1.5 | -49.2% | 40,419 | +102.5% | China 45% ($39,566) · Finland 30% ($45,869) · Belgium 21% ($37,336) · Taiwan 2% ($37,872) · United Kingdom 1% ($18,181) |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑨ 나프타 — 한국 수입 물량·단가와 브렌트Naphtha — Korea’s import volume and unit price, and Brentナフサ — 韓国の輸入数量・単価とブレント
kt · USD/t · USD/bbl · Data as of 2026-09 · Created 2026-11-13나프타는 크래커의 원료다 — 에틸렌·프로필렌·부타디엔·벤젠이 여기서 나와 이 네 회사의 원료(또는 원료의 원료)가 된다. 최근 12개월 수입 20953kt(전년 대비 -23.7%), 단가 $713/t(전년 대비 +12.3%). 주요 원산국: UAE 16% · Algeria 16% · United States 11% · Oman 9% · India 8%. 수입 단가는 브렌트 당월·전월·전전월 값으로 설명된다(월별 적합 R² 0.91) — 이 다리로 관세청이 아직 없는 달을 잇는다.Naphtha is the feedstock of crackers — ethylene, propylene, butadiene and benzene come out of it and become the raw materials (or the raw materials’ raw materials) of these four companies. Imports over the latest 12 months 20953 kt (-23.7% YoY), unit price $713/t (+12.3% YoY). Main origins: UAE 16% · Algeria 16% · United States 11% · Oman 9% · India 8%. The import unit price is explained by Brent in the same month and the two months before (monthly fit R² 0.91) — this bridge links the months for which customs data are not out yet.ナフサはクラッカーの原料だ — エチレン・プロピレン・ブタジエン・ベンゼンがここから生まれ、この4社の原料(または原料の原料)になる。直近12か月の輸入20953kt(前年比-23.7%)、単価$713/t(前年比+12.3%)。主な原産国: UAE 16% · Algeria 16% · United States 11% · Oman 9% · India 8%。輸入単価はブレントの当月・前月・前々月の値で説明される(月次の当てはまりR² 0.91)— このブリッジで関税庁のデータがまだない月をつなぐ。
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑩ 우리 Fcst — 관세청 단가로 세운 이익률, 유가로 잇는 다음 분기Our Fcst — a margin built on customs unit prices, bridged to the next quarters by oil当サイトFcst — 関税庁の単価で立てた利益率、原油でつなぐ次の四半期
% · USD/t · Data as of 2026-09 · Created 2026-11-13대상: 별도 분기 영업이익률, 2022Q1~2026Q2(18분기). 스프레드 = 양극재(NCM·NCA·NCMA) 수출 단가 − (리튬·전구체·코발트, 매입액 가중) 수입 단가. 양극재·리튬은 유가와 무관 → 관세청 마지막 3개월 단가 유지. 전진 검증(그 분기 전 자료로만 맞추고 그 분기를 맞힘) 평균 오차: 고른 모델(차분 모델(스프레드 변화)) 1.05%p vs 직전 분기 유지 1.25%p — 모델이 직전 분기보다 낫다. 전 기간 적합 R² 0.09. 202609 까지는 관세청 실측 단가, 그 뒤는 브렌트를 마지막 달 평균($107.2/bbl)으로 둔 다리다(이 회사 원료·제품은 유가와 무관해 마지막 3개월 단가를 유지). 유가 경로 자체는 모델 밖이다.Target: separate quarterly operating margin, 2022Q1–2026Q2 (18 quarters). Spread = 양극재(NCM·NCA·NCMA) 수출 단가 − (리튬·전구체·코발트, 매입액 가중) 수입 단가. 양극재·리튬은 유가와 무관 → 관세청 마지막 3개월 단가 유지. Mean forward-test error (fitted only on data from before each quarter, then scored on it): chosen model (difference model (spread change)) 1.05pp vs 1.25pp for the previous quarter carried forward — the model does better than the previous quarter. Full-period fit R² 0.09. Up to 202609, measured customs unit prices; after that, a bridge holding Brent at the last month’s average ($107.2/bbl) (this company’s raw materials and products are unrelated to oil, so the last three months’ unit prices are held). The oil path itself is outside the model.対象: 個別の四半期営業利益率、2022Q1〜2026Q2(18四半期)。スプレッド = 양극재(NCM·NCA·NCMA) 수출 단가 − (리튬·전구체·코발트, 매입액 가중) 수입 단가。양극재·리튬은 유가와 무관 → 관세청 마지막 3개월 단가 유지。フォワードテスト(その四半期より前のデータだけで当てはめてその四半期を当てる)の平均誤差: 選んだモデル(差分モデル(スプレッドの変化))1.05%pt 対 前四半期据え置き 1.25%pt — モデルが前四半期より良い。全期間の当てはまりR² 0.09。202609までは関税庁の実測単価、その後はブレントを最終月の平均($107.2/bbl)に置いたブリッジだ(この会社の原料・製品は原油と無関係なため、直近3か月の単価を維持)。原油の経路そのものはモデルの外だ。
| 분기Quarter四半期 | 관세청 실측 달Customs months observed関税庁の実測月 | 영업이익률Operating margin営業利益率 | 매출(억원)Revenue (KRW 100mn)売上高(億ウォン) | 영업이익(억원)Operating profit (KRW 100mn)営業利益(億ウォン) |
|---|---|---|---|---|
| 2026Q3 Fcst | 3/3 | 3.9% | 1,417 | 56 |
| 2026Q4 Fcst | 0/3 | 3.9% | 1,346 | 53 |
| 2027Q1 Fcst | 0/3 | 3.9% | 1,350 | 53 |
| 2027Q2 Fcst | 0/3 | 3.9% | 1,350 | 53 |
| 2027Q3 Fcst | 0/3 | 3.9% | 1,350 | 53 |
| 2027Q4 Fcst | 0/3 | 3.9% | 1,350 | 53 |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑪ 분기 실적 · P/B · ROEQuarterly results · P/B · ROE四半期業績 · PBR · ROE
% · x · Data as of 2026-06-30 · Created 2026-11-13P/B = 분기말(이하 마지막 거래일) 보통주·우선주 시가총액 ÷ 분기말 지배주주 자본. ROE = 최근 4분기 지배주주 순이익 ÷ 평균 지배주주 자본. 현재 P/B 2.07배(2026-11-10 시세 ÷ 2026-06-30 자본).P/B = market capitalisation of common and preferred shares at quarter-end (the last trading day) ÷ quarter-end equity attributable to owners of the parent. ROE = net profit attributable to owners of the parent over the last four quarters ÷ average equity attributable to owners. Current P/B 2.07x (2026-11-10 price ÷ 2026-06-30 equity).PBR = 四半期末(最終取引日)の普通株・優先株の時価総額 ÷ 四半期末の親会社株主に帰属する自己資本。ROE = 直近4四半期の親会社株主に帰属する当期純利益 ÷ 平均の親会社株主資本。現在のPBR 2.07倍(2026-11-10の株価 ÷ 2026-06-30の資本)。
| 연도Year年 | 매출Revenue売上高 | 영업이익Operating profit営業利益 | 지배 순이익Net profit (owners)親会社株主純利益 | 영업현금흐름Operating cash flow営業キャッシュフロー | 설비투자Capex設備投資 | FCF | 배당 지급Dividends paid配当支払 | 자사주 취득Share buybacks自己株式取得 |
|---|---|---|---|---|---|---|---|---|
| 2025 | 4,563 | 24 | -5 | 1,382 | 458 | 924 | — | — |
| 2024 | 5,697 | 250 | 176 | 91 | 1,880 | -1,789 | — | — |
| 2023 | 6,296 | 323 | 270 | -289 | 1,021 | -1,310 | — | — |
| 2022 | 4,856 | 325 | 277 | 5 | 202 | -197 | — | — |
| 2021 | 3,059 | 218 | 180 | 260 | 410 | -150 | — | — |
| 2020 | 2,043 | 124 | 117 | -19 | 281 | -299 | — | — |
| 2019 | 2,439 | -36 | -18 | 0 | 87 | -87 | — | — |
| 2018 | 5,340 | 151 | 104 | 97 | 238 | -141 | — | 2 |
| 2017 | 3,146 | 85 | 82 | -12 | 119 | -132 | — | — |
| 2016 | 1,903 | 50 | 14 | 107 | 16 | 91 | — | — |
| 2015 | 1,334 | -70 | -247 | 101 | 1 | 100 | — | — |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑫ 네 회사 나란히 — 복합 vs 단순The four companies side by side — complex vs simple4社を並べて — 複合 vs 単純
Data as of 2025-12 · Created 2026-11-13같은 기준으로 고객·제품·원료가 얼마나 흩어져 있는지 셌다. 부문 집중도는 부문 매출 비중 제곱의 합(1 = 한 부문). 마지막 열 둘은 우리 Fcst 의 전진 오차 — 구조가 단순하다고 이익률이 원료 스프레드를 더 잘 따라가는 것은 아니다(각 회사 페이지의 Fcst 절).On the same basis, a count of how widely customers, products and raw materials are spread. Segment concentration is the sum of squared segment revenue shares (1 = a single segment). The last two columns are our Fcst’s forward errors — a simpler structure does not mean the margin tracks the raw-material spread better (see the Fcst section on each company page).同じ基準で、顧客・製品・原料がどれだけ分散しているかを数えた。部門集中度は部門売上比率の二乗和(1 = 単一部門)。最後の2列は当サイトFcstのフォワード誤差 — 構造が単純だからといって利益率が原料スプレッドによりよく追随するわけではない(各社ページのFcstの節)。
| 회사Company会社 | 부문 수Segments部門数 | 부문 집중도Segment concentration部門集中度 | 10% 고객 합10% customers, total10%顧客の合計 | 수출 비중Export share輸出比率 | 최대 원재료 비중Largest raw-material share最大原材料比率 | 짝지은 제품·원료Matched products · inputs対応させた製品・原料 | Fcst 오차 vs 직전 분기Fcst error vs previous quarterFcst誤差 vs 前四半期 | P/BP/BPBR | Fwd P/EFwd P/E予想PER |
|---|---|---|---|---|---|---|---|---|---|
| LG화학LG ChemLG Chem | 5 | 0.42 | 11% | 47% | 48% | 18 · 11 | 2.2 vs 3.5%ppp%pt | 0.50 | — |
| 코스모신소재Cosmo Advanced Materials & TechnologyCosmo Advanced Materials & Technology | 1 | 1.00 | 85% | 42% | 73% | 4 · 5 | 1.1 vs 1.2%ppp%pt | 2.07 | 77.9 |
| 금호석유화학Kumho PetrochemicalKumho Petrochemical | 3 | 0.47 | 없음noneなし | 69% | 57% | 11 · 7 | 3.8 vs 4.1%ppp%pt | 0.39 | 4.1 |
| KPX케미칼KPX ChemicalKPX Chemical | 1 | 1.00 | 11% | 63% | 71% | 1 · 2 | 1.9 vs 1.9%ppp%pt | 0.31 | 5.0 |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage